quinazolines has been researched along with Soft Tissue Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, C; Bhadri, V; Bliss, JM; Campbell-Hewson, Q; Cubedo, R; Dangoor, A; Fox, L; Hennig, I; Jarman, K; Joubert, W; Judson, I; Kernaghan, S; Kilburn, L; Leahy, M; López Pousa, A; Martinez Trufero, J; McNeil, C; Morden, JP; Seddon, B; Snowdon, C; Tattersall, M; Toms, C | 1 |
| Kataoka, K; Okamura, Y; Osaka, E; Shimizu, T; Tokuhashi, Y; Yoshida, Y | 1 |
| Aboulafia, AJ; Cummings, JE; Damron, TA; Joyner, DE; Randall, RL; Trang, SH | 1 |
| Badinloo, M; Hajializadeh, Z; Jangi-Aghdam, H; Pooraboli, I; Rajabalian, S | 1 |
| Bahleda, R; Blay, JY; Dieras, V; LoRusso, P; Macaulay, VM; Mery-Mignard, D; Middleton, MR; Protheroe, AS; Sessa, C; Soria, JC; Tolcher, A | 1 |
| Markó, L; Sárkány, J; Szûcs, M; Tóth, K | 1 |
| Albanell, J; Baselga, J; Gascón, P; González, S; Guillém, V; Koehler, MT; Lluch, A; Marimón, I; Rojo, F; Ruiz, A; Sauleda, S; Tabernero, JM | 1 |
| Blay, JY; Hermans, C; Judson, I; Rodenhuis, S; Smith, M; van Glabbeke, M; Verweij, J | 1 |
| Antman, KH; Gonin, R; Licht, JD | 1 |
4 trial(s) available for quinazolines and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinazolines; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Young Adult | 2019 |
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Melanoma; Middle Aged; Quinazolines; Receptor, IGF Type 1; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Treatment Outcome | 2013 |
Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Bone Neoplasms; Breast Neoplasms; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Humans; Ki-67 Antigen; Male; Maximum Tolerated Dose; Middle Aged; Mitogen-Activated Protein Kinases; Phosphorylation; Quinazolines; Salvage Therapy; Soft Tissue Neoplasms; Treatment Outcome; Tumor Suppressor Proteins | 2005 |
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Quinazolines; Sarcoma; Soft Tissue Neoplasms; Thiophenes; Thrombocytopenia; Treatment Outcome | 1999 |
5 other study(ies) available for quinazolines and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare case.
Topics: Arm; Carcinoma, Squamous Cell; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Mutation; Quinazolines; Soft Tissue Neoplasms; Treatment Outcome | 2016 |
Desmoid cell motility is induced in vitro by rhEGF.
Topics: Benzamides; Cell Division; Cell Line, Tumor; Cell Movement; Culture Media, Serum-Free; Dioxoles; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Fibromatosis, Aggressive; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Integrin beta1; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Quinazolines; Receptors, Transforming Growth Factor beta; Recombinant Proteins; RNA, Messenger; RNA, Small Interfering; Soft Tissue Neoplasms; STAT3 Transcription Factor; Transforming Growth Factor alpha; Tyrphostins | 2009 |
Establishment, characterization, and drug sensitivity of a new Ewing sarcoma cell line (SS-ES-1).
Topics: Adolescent; Antineoplastic Agents; Biomarkers, Tumor; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Female; Humans; Neoplasm Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Quinazolines; RNA-Binding Protein EWS; Sarcoma, Ewing; Soft Tissue Neoplasms; Tamoxifen; Tyrphostins | 2010 |
[The rare manifestation of soft tissue metastasis in colorectal cancer].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fatal Outcome; Humans; Male; Quinazolines; Soft Tissue Neoplasms; Thiophenes | 2002 |
Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma.
Topics: Antineoplastic Agents; Drug Evaluation; Folic Acid Antagonists; Humans; Infusions, Intravenous; Quinazolines; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Time Factors; Trimetrexate | 1991 |